Avadel Pharmaceuticals (AVDL) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.32
-0.22
-0.13
-0.03

Details

Expected EPS
-0.081667
Actual EPS
-0.03
Surprise EPS
0.05
Surprise Percent
+63.27%

Description

Avadel Pharmaceuticals (AVDL) has reported earnings of -0.03 per share for Q4 2024.

0 Comments

Share your thoughts